IsoPlexis
Branford
About IsoPlexis
IsoPlexis is a life science technology company developing a single-cell detection system that identifies a wide range of patient immune responses at the single-cell level. Its platform can assess the safety and efficacy of therapeutics and monitor disease progression, enabling improved therapeutic development, and informing physician decisions. The company was founded in 2013 and is headquartered in Branford, Connecticut.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $205.1M
- Funding stage: M&A
- Last round: Series D (Jan 2021)
- Ticker: nasdaq:ISO
- Website: isoplexis.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/isoplexis-11386 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.